| 前收市價 | 40.91 |
| 開市 | 41.00 |
| 買盤 | 40.74 x 100 |
| 賣出價 | 40.87 x 100 |
| 今日波幅 | 40.77 - 41.53 |
| 52 週波幅 | 34.32 - 54.44 |
| 成交量 | |
| 平均成交量 | 1,100,312 |
| 市值 | 5.948B |
| Beta 值 (5 年，每月) | 0.40 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.56 |
| 業績公佈日 | 2024年5月01日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 55.95 |
ZacksCan Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
Ionis' (IONS) collaboration revenues enable it to invest in its wholly-owned pipeline. This is expected to enhance Ionis' already diverse revenue streams.
ZacksIonis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insider Monkey30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
